Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 123 results found. Search for [ SII COVID-19 vaccine in UK ]

Results 1 to 21 of 123
PTI
May 4, 2021
COVAX urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX's main supplier of the AstraZeneca product is based, according to WHO


PTI
May 4, 2021
The investments confirmed by Downing Street form part of an Enhanced Trade Partnership (ETP), which UK PM Boris Johnson and his Indian counterpart Narendra Modi will formally sign off during their talks


BusinessToday.In
May 3, 2021
Poonawalla said SII has got 100 per cent advance of Rs 1,732.50 crore by GoI for the next tranche of 11 crore doses in the next few months.


BusinessToday.In
May 2, 2021
Earlier, Poonawalla had dropped a bombshell by saying in an interview he had extended his stay in London because of the threatening phone calls he had been receiving.


BusinessToday.In
May 1, 2021
Poonawalla said he had been getting phone calls from the \"most powerful\" in India, including chief ministers, business leaders and others for immediate supply of Covishield vaccine.


BusinessToday.In
April 22, 2021
If the coronavirus vaccine developed by Biological E gets emergency authorisation, it will be the fourth vaccine against coronavirus in India


BusinessToday.In
April 21, 2021
Over the past 50 days, 9.78 crore Indians got the first shot of the vaccine, whereas the second dose was administered to a little over 1.5 crore Indians


PTI
April 21, 2021
Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India


Manoj Sharma
April 20, 2021
If their previous statements are any indication, hiked prices of vaccines could be anywhere between Rs 1,000- Rs 2,000. Poonawalla had earlier said the vaccine could be sold at Rs 1,000 per dose to private players, while Bharat Biotech's Krishna Ella said prices were likely to go up initially


BusinessToday.In
April 9, 2021
The move by the national committee on adverse effects following immunisation (AEFI) has come after the European's regulator said it found rare cases of blood clots among some adult recipients who were given AstraZeneca-Oxford university's vaccine shots


BusinessToday.In
April 8, 2021
Adar Poonawalla said that SII has submitted a formal proposal for an upfront grant from the government. It is otherwise difficult to ramp up as they have already poured in thousands of crores and borrowed Rs 1,500 crore, he said


BusinessToday.In
New Delhi, April 8, 2021
Serum Institute of India CEO Adar Poonawalla on Tuesday said that the effectiveness of the Covishield vaccine rises to as much as 90 per cent if the two shots are separated by about 2.5-3 months. Speaking to India Today, Poonawalla added that no COVID-19 vaccine is preventing more than 20-30 per cent of recipients from getting the disease. He said that the vaccine acts as a shield, which prevents anyone from going to the hospital and the same applies to different virus mutations. He also said that immunity kicks in one month after taking the first dose of the Covishield vaccine. Watch the video for more.Watch More | Is Covishield safe for people with low immunity? CEO of SII replies


BusinessToday.In
April 6, 2021
Adar says Covishield has found an excellent response below the age of 50 with one dose. About 70 per cent of people are fully protected with one dose, but the second dose is necessary for long-term immunity protection, he adds


BusinessToday.In
March 31, 2021
The Drug Controller General of India (DCGI) has allowed the extension of AstraZeneca coronavirus vaccine's expiration time period from the earlier prescribed six months


BusinessToday.In
March 27, 2021
SII has signed an agreement with Novavax to manufacture a vaccine with the name 'Covovax' in India. Novavax has announced final efficacy of 96.4 per cent against original COVID-19 virus. Novavax with Serum will provide 1.1 billion cumulative doses for COVAX Facility


BusinessToday.In
March 25, 2021
The property leased by Serum CEO Adar Poonawalla is one of the largest residences in the neighbourhood measuring approx. 25,000 sq. ft (2,322 square meters), the equivalent of around 24 average English homes


Joe C Mathew
March 3, 2021
Over 110 million doses of this to about 60 countries will be met through the AstraZeneca (AZ)-Serum Institute of India partnership


Rashi Bisaria
New Delhi, March 3, 2021
India's fuel demand to rise 9.8% in year to March 2022 India's fuel consumption could rise by 9.8% in the year to March 2022, its highest pace of growth in six years, driven by robust demand for gasoline and gasoil in Asia's third largest economy, according to initial government projections. Higher expectation of fuel consumption, a proxy for oil demand, points to a sharp recovery in industrial activity in the economy hit hard by the pandemic. Economic recovery lost steam in Jan-Feb: Axis...


Reuters
March 3, 2021
\"The UK has ordered 100 million doses of AstraZeneca's COVID-19 vaccine, of which 10 million doses will come from the Serum Institute of India,\" a UK government spokesperson told Reuters


Reuters
March 1, 2021
Some 500,000 doses made by SII, the world's largest vaccine producer, are set to arrive in Canada on Wednesday, a surprise boost for Canada's lagging vaccination drive


PAGES 1 OF 7  12345